Stratified by cancer type, high RNA expression of VISTA was most commonly observed in small intestine cancer [75% (9/12)], followed by stomach cancer [56% (14/25)], pancreatic cancer [52.7% (29/55)], sarcoma [37.5% (9/24)], and neuroendocrine tumors [33.3% (5/15)] [all listed above had more than the average proportion among all cancer types (32.3%)]. Here, VSIR is linked to sarcoma.